Tirzepatide pens contain a high-purity peptide (99%) that functions as a dual agonist of both GIP and GLP-1 receptors. This innovative compound combines two insulinotropic effects in a single molecule, making it valuable for metabolic research applications.
The product appears as white lyophilized powder requiring reconstitution before use. Each vial contains precisely measured tirzepatide in research-grade purity, packaged in secure vials to maintain stability.
As a GLP-1 receptor agonist, tirzepatide pens offer researchers a tool to study metabolic pathways and potential weight management applications. The compound's molecular structure (C225H348N48O68) and weight (4813.527g/mol) have been carefully characterized.
Our manufacturing process ensures batch-to-batch consistency in tirzepatide pens, with rigorous quality control at each production stage. The lyophilized formulation provides extended stability when stored properly.
For research institutions requiring larger quantities, we offer bulk packaging options and custom concentration specifications. All tirzepatide pens are supplied for laboratory research purposes only.